Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Dual mode of glucagon receptor internalization: role of PKCα, GRKs and β-arrestins.

Krilov L, Nguyen A, Miyazaki T, Unson CG, Williams R, Lee NH, Ceryak S, Bouscarel B.

Exp Cell Res. 2011 Dec 10;317(20):2981-94. doi: 10.1016/j.yexcr.2011.10.001. Epub 2011 Oct 6.

2.

Monitoring glucagon and glucagon antagonist-mediated internalization: a useful approach to study glucagon receptor pharmacology.

Sachdev P, Tirunagari LM, Kappei D, Unson CG.

Adv Exp Med Biol. 2009;611:325-6. No abstract available.

PMID:
19400212
3.

Glucagon receptor recycling: role of carboxyl terminus, beta-arrestins, and cytoskeleton.

Krilov L, Nguyen A, Miyazaki T, Unson CG, Bouscarel B.

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1230-7. doi: 10.1152/ajpcell.00240.2008. Epub 2008 Sep 11.

4.

Merrifield laboratory: last member standing.

Unson CG.

Biopolymers. 2008;90(3):243-4. doi: 10.1002/bip.20942. No abstract available.

PMID:
18428162
6.
7.

Glucagon-mediated internalization of serine-phosphorylated glucagon receptor and Gsalpha in rat liver.

Merlen C, Fabrega S, Desbuquois B, Unson CG, Authier F.

FEBS Lett. 2006 Oct 16;580(24):5697-704. Epub 2006 Sep 20.

8.

Adherence to calcium/vitamin D and estrogen protocols among diverse older participants enrolled in a clinical trial.

Unson CG, Litt M, Reisine S, Mahoney-Trella P, Sheperd T, Prestwood K.

Contemp Clin Trials. 2006 Jun;27(3):215-26. Epub 2006 Apr 3.

PMID:
16581307
9.
10.

Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors.

Unson CG, Fortinsky R, Prestwood K, Reisine S.

J Community Health. 2005 Aug;30(4):281-97.

PMID:
15989210
11.

Strategies for enrolling diverse older women in an osteoporosis trial.

Unson CG, Ohannessian C, Kenyon L, Fenster J, Reisine S, Prestwood K.

J Aging Health. 2004 Nov;16(5):669-87.

PMID:
15448277
12.

Barriers to eligibility and enrollment among older women in a clinical trial on osteoporosis: effects of ethnicity and SES.

Unson CG, Ohannessian C, Kenyon L, Case A, Reisine S, Prestwood K.

J Aging Health. 2004 Jun;16(3):426-43.

PMID:
15155070
13.

Nonadherence and osteoporosis treatment preferences of older women: a qualitative study.

Unson CG, Siccion E, Gaztambide J, Gaztambide S, Mahoney Trella P, Prestwood K.

J Womens Health (Larchmt). 2003 Dec;12(10):1037-45.

PMID:
14709192
14.

Molecular determinants of glucagon receptor signaling.

Unson CG.

Biopolymers. 2002;66(4):218-35. Review.

PMID:
12491536
16.

Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.

Unson CG, Wu CR, Jiang Y, Yoo B, Cheung C, Sakmar TP, Merrifield RB.

Biochemistry. 2002 Oct 1;41(39):11795-803.

PMID:
12269822
17.
18.

Glucagon receptor activates extracellular signal-regulated protein kinase 1/2 via cAMP-dependent protein kinase.

Jiang Y, Cypess AM, Muse ED, Wu CR, Unson CG, Merrifield RB, Sakmar TP.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10102-7. Epub 2001 Aug 21.

19.
20.

Two cytoplasmic loops of the glucagon receptor are required to elevate cAMP or intracellular calcium.

Cypess AM, Unson CG, Wu CR, Sakmar TP.

J Biol Chem. 1999 Jul 2;274(27):19455-64.

21.

Positively charged residues at positions 12, 17, and 18 of glucagon ensure maximum biological potency.

Unson CG, Wu CR, Cheung CP, Merrifield RB.

J Biol Chem. 1998 Apr 24;273(17):10308-12.

22.

Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.

Kieffer TJ, Heller RS, Unson CG, Weir GC, Habener JF.

Endocrinology. 1996 Nov;137(11):5119-25.

PMID:
8895386
23.

Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding.

Unson CG, Cypess AM, Wu CR, Goldsmith PK, Merrifield RB, Sakmar TP.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):310-5.

24.
25.
26.

Roles of aspartic acid 15 and 21 in glucagon action: receptor anchor and surrogates for aspartic acid 9.

Unson CG, Wu CR, Merrifield RB.

Biochemistry. 1994 Jun 7;33(22):6884-7.

PMID:
8204623
27.

Multiple-site replacement analogs of glucagon. A molecular basis for antagonist design.

Unson CG, Wu CR, Fitzpatrick KJ, Merrifield RB.

J Biol Chem. 1994 Apr 29;269(17):12548-51.

28.

Identification of an essential serine residue in glucagon: implication for an active site triad.

Unson CG, Merrifield RB.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):454-8.

29.

The role of histidine-1 in glucagon action.

Unson CG, Macdonald D, Merrifield RB.

Arch Biochem Biophys. 1993 Feb 1;300(2):747-50.

PMID:
8382034
30.

The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family.

Shenker A, Goldsmith P, Unson CG, Spiegel AM.

J Biol Chem. 1991 May 15;266(14):9309-13.

31.

G-protein beta gamma dimers. Membrane targeting requires subunit coexpression and intact gamma C-A-A-X domain.

Simonds WF, Butrynski JE, Gautam N, Unson CG, Spiegel AM.

J Biol Chem. 1991 Mar 25;266(9):5363-6.

32.

Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding.

Unson CG, Macdonald D, Ray K, Durrah TL, Merrifield RB.

J Biol Chem. 1991 Feb 15;266(5):2763-6.

33.

The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family.

Shenker A, Goldsmith P, Unson CG, Spiegel AM.

Trans Assoc Am Physicians. 1991;104:11-20. No abstract available.

PMID:
1845138
34.
35.

Antibodies as probes of G-protein receptor-effector coupling and of G-protein membrane attachment.

Spiegel AM, Simonds WF, Jones TL, Goldsmith PK, Unson CG.

Biochem Soc Symp. 1990;56:61-9. Review.

PMID:
2175191
36.

Antibodies against synthetic peptides as probes of G protein structure and function.

Spiegel AM, Simonds WF, Jones TL, Goldsmith PK, Unson CG.

Soc Gen Physiol Ser. 1990;45:185-95. Review. No abstract available.

PMID:
2116039
37.

Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist.

Unson CG, Gurzenda EM, Merrifield RB.

Peptides. 1989 Nov-Dec;10(6):1171-7.

PMID:
2560175
38.

Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies.

Simonds WF, Goldsmith PK, Codina J, Unson CG, Spiegel AM.

Proc Natl Acad Sci U S A. 1989 Oct;86(20):7809-13.

40.
41.

Receptor and effector interactions of Gs. Functional studies with antibodies to the alpha s carboxyl-terminal decapeptide.

Simonds WF, Goldsmith PK, Woodard CJ, Unson CG, Spiegel AM.

FEBS Lett. 1989 Jun 5;249(2):189-94.

42.
43.

Potentiation of glucose-induced insulin release in islets by desHis1[Glu9]glucagon amide.

Kofod H, Unson CG, Merrifield RB.

Int J Pept Protein Res. 1988 Dec;32(6):436-40.

PMID:
3073146
45.

Purification of heterotrimeric GTP-binding proteins from brain: identification of a novel form of Go.

Goldsmith P, Backlund PS Jr, Rossiter K, Carter A, Milligan G, Unson CG, Spiegel A.

Biochemistry. 1988 Sep 6;27(18):7085-90.

PMID:
3143408
46.

GTP analogues promote release of the alpha subunit of the guanine nucleotide binding protein, Gi2, from membranes of rat glioma C6 BU1 cells.

Milligan G, Mullaney I, Unson CG, Marshall L, Spiegel AM, McArdle H.

Biochem J. 1988 Sep 1;254(2):391-6.

47.

The use of anti-peptide antisera to probe interactions between receptors and guanine nucleotide binding proteins.

McKenzie FR, Mullaney I, Unson CG, Spiegel AM, Milligan G.

Biochem Soc Trans. 1988 Aug;16(4):434-7. Review. No abstract available.

PMID:
2850230
48.

Identification of the GTP-binding protein encoded by Gi3 complementary DNA.

Goldsmith P, Rossiter K, Carter A, Simonds W, Unson CG, Vinitsky R, Spiegel AM.

J Biol Chem. 1988 May 15;263(14):6476-9.

49.

Immunochemical and electrophoretic characterization of the major pertussis toxin substrate of the RAW264 macrophage cell line.

Backlund PS Jr, Aksamit RR, Unson CG, Goldsmith P, Spiegel AM, Milligan G.

Biochemistry. 1988 Mar 22;27(6):2040-6.

PMID:
3132205
50.

Selective deficiency of guanine nucleotide-binding protein Go in two dopamine-resistant pituitary tumors.

Collu R, Bouvier C, Lagacé G, Unson CG, Milligan G, Goldsmith P, Spiegel AM.

Endocrinology. 1988 Mar;122(3):1176-8.

PMID:
3125040

Supplemental Content

Loading ...
Support Center